Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AposTherapy System

K-Number: K182090 · 2018-11-16

ApplicantApos Medical Assets , Ltd.
Decision Date2018-11-16
Product CodeQDT
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

AposTherapy System is a medical device manufactured by Apos Medical Assets , Ltd.. It received FDA 510(k) clearance on 2018-11-16 under approval number K182090. The device is classified under product code QDT. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AposTherapy System?

AposTherapy System is a medical device that received FDA 510(k) clearance on 2018-11-16. It is manufactured by Apos Medical Assets , Ltd.. The 510(k) number is K182090.

When was AposTherapy System approved by the FDA?

AposTherapy System received FDA 510(k) clearance on 2018-11-16, under approval number K182090.

What company makes AposTherapy System?

AposTherapy System is manufactured by Apos Medical Assets , Ltd..

What is the FDA product code for AposTherapy System?

The FDA product code for AposTherapy System is QDT.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑